- Trials with a EudraCT protocol (34)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
34 result(s) found for: Incision and drainage.
Displaying page 1 of 2.
EudraCT Number: 2006-001599-18 | Sponsor Protocol Number: BAY 12-8039/11974 | Start Date*: 2006-11-03 | |||||||||||
Sponsor Name:Bayer HealthCare AG | |||||||||||||
Full Title: A prospective, randomized, double dummy, double blind, multinational, multicenter trial comparing the safety and efficacy of sequential (intravenous/oral) moxifloxacin 400 mg once daily to intraven... | |||||||||||||
Medical condition: complicated skin and skin structure Infections | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) LT (Completed) BE (Completed) LV (Completed) FR (Completed) GR (Completed) IE (Completed) HU (Completed) ES (Completed) NL (Prematurely Ended) AT (Completed) IT (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-001082-17 | Sponsor Protocol Number: DELA-01 | Start Date*: 2019-08-19 | |||||||||||
Sponsor Name:MENARINI RICERCHE S.p.A. | |||||||||||||
Full Title: A randomized, observer-blinded, active-controlled, Phase IIIb study to compare IV / Oral delafloxacin fixed-dose monotherapy with best available treatments in a microbiologically enriched populatio... | |||||||||||||
Medical condition: Acute Bacterial Skin and Skin Structure Infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Prematurely Ended) GB (Prematurely Ended) HU (Prematurely Ended) LV (Prematurely Ended) SI (Prematurely Ended) ES (Prematurely Ended) AT (Prematurely Ended) PL (Prematurely Ended) EE (Prematurely Ended) BG (Prematurely Ended) HR (Completed) IT (Prematurely Ended) RO (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-001155-22 | Sponsor Protocol Number: Lap2014NMB | Start Date*: 2014-05-22 | ||||||||||||||||
Sponsor Name:Mona Ring Gätke | ||||||||||||||||||
Full Title: Muscle relaxation during open upper abdominal surgery -can the surgical conditions be optimized? (The laparotomy study) | ||||||||||||||||||
Medical condition: The aim of the study is to investigate if intense NMB improves surgical conditions during operation in patients scheduled for elective open upper abdominal surgery. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-003828-21 | Sponsor Protocol Number: 71617 | Start Date*: 2020-02-10 |
Sponsor Name:St Antonius Hospital | ||
Full Title: Identification of sentinel lymph nodes in breast cancer patients through non-invasively and percutaneously fluorescent imaging using indocyanine green | ||
Medical condition: Axillar staging in breast cancer patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-022168-11 | Sponsor Protocol Number: TR-701-112 | Start Date*: 2011-03-08 | |||||||||||
Sponsor Name:Trius Therapeutics, Inc. | |||||||||||||
Full Title: A Phase 3 Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of 6-Day Oral TR-701 Free Acid and 10-Day Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin... | |||||||||||||
Medical condition: Acute Bacterial Skin and Skin Structure Infections | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) CZ (Completed) LV (Completed) HU (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-001605-32 | Sponsor Protocol Number: BPR-CS-008 | Start Date*: 2017-10-06 | |||||||||||
Sponsor Name:Basilea Pharmaceutica International Ltd | |||||||||||||
Full Title: A randomized, double-blind, multicenter study to establish the safety and efficacy of ceftobiprole medocaril compared with vancomycin plus aztreonam in the treatment of acute bacterial skin and ski... | |||||||||||||
Medical condition: Acute bacterial skin and skin structure infections | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000334-59 | Sponsor Protocol Number: PI2017_843_0002 | Start Date*: 2018-06-05 |
Sponsor Name:CHU Amiens-Picardie | ||
Full Title: The value of post-operative antibiotic therapy after laparoscopic appendectomy for complicated acute appendicitis (other than for generalized peritonitis): a prospective, randomized, placebo-contro... | ||
Medical condition: The value of post-operative antibiotic therapy after laparoscopic appendectomy for complicated acute appendicitis (other than for generalized peritonitis): a prospective, randomized, placebo-contro... | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2005-002239-29 | Sponsor Protocol Number: WI18274 | Start Date*: 2006-03-06 |
Sponsor Name:F. Hoffmann - La Roche AG | ||
Full Title: A phase II prospective, open label, randomized, active-controlled, parallel group, multi-center ‘proof of concept’ trial in adult patients with complicated skin and skin structure infections requir... | ||
Medical condition: Treatment of adult patients with complicated skin and skin structure infections requiring hospitalization. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: LT (Completed) EE (Completed) DE (Completed) LV (Completed) HU (Completed) GR (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-003217-11 | Sponsor Protocol Number: NL82304.058.22 | Start Date*: 2023-02-24 | |||||||||||||||||||||
Sponsor Name:Leiden University Medical Center | |||||||||||||||||||||||
Full Title: Standard versus Pre-emptive Antibiotic Treatment to Reduce the Rate of Infectious Outcomes after Whipple procedure (SPARROW): a multicenter, randomized controlled trial | |||||||||||||||||||||||
Medical condition: Pancreatic head malignancy | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Trial now transitioned) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000942-36 | Sponsor Protocol Number: POWAR | Start Date*: 2012-10-22 | |||||||||||
Sponsor Name:Guys and St Thomas NHS Foundation Trust | |||||||||||||
Full Title: Are phrophylactic antibiotics necessary before laparoscopic living kidney donation? A double blind, randomised, controlled trial. | |||||||||||||
Medical condition: Post-operative infections | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002860-26 | Sponsor Protocol Number: TR701-113 | Start Date*: 2011-12-21 | |||||||||||
Sponsor Name:Trius Therapeutics, Inc. | |||||||||||||
Full Title: A Phase 3 Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous to Oral 6-Day TR-701 Free Acid and Intravenous to Oral 10-Day Linezolid for the Treatment of... | |||||||||||||
Medical condition: Acute Bacterial Skin and Skin Structure Infections | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-002301-23 | Sponsor Protocol Number: BAP00414 | Start Date*: 2005-12-14 | |||||||||||
Sponsor Name:Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind Study Of Ceftobiprole Medocaril Versus Vancomycin With Ceftazidime in The Treatment Of Complicated Skin And Skin Structure Infections | |||||||||||||
Medical condition: complicated skin and skin structure infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) LV (Completed) LT (Completed) EE (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-003697-93 | Sponsor Protocol Number: OXITIB2011 | Start Date*: 2011-12-15 | |||||||||||
Sponsor Name:Hospital Universitario de Canarias | |||||||||||||
Full Title: Effectiveness of hyperbaric oxygen therapy in the treatment of the open tibial fractures. Open clinical trial, randomized, prospective and controlled. | |||||||||||||
Medical condition: Open tibial fractures | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004013-16 | Sponsor Protocol Number: D3720C00001 | Start Date*: 2012-03-08 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A Phase III, Multicentre, Randomised, Double-Blind, Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600mg every 8 hours) Versus Vancomycin Plus Aztreonam in the Treatm... | |||||||||||||
Medical condition: Complicated bacterial skin and soft tissue infections | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GR (Completed) BE (Completed) CZ (Completed) BG (Completed) DE (Completed) AT (Completed) PL (Completed) ES (Completed) GB (Completed) SK (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-014391-22 | Sponsor Protocol Number: CCBC134A2404 | Start Date*: Information not available in EudraCT |
Sponsor Name:Novartis Pharma AG | ||
Full Title: An open label, multi-center, randomized, comparative Phase IIIb study to compare efficacy and safety of intravenous (i.v.) daptomycin with that of Semi-synthetic Penicillins (SSPs) or vancomycin in... | ||
Medical condition: complicated skin and soft tissue infections. | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) IT (Completed) ES (Completed) AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-024042-30 | Sponsor Protocol Number: DUR001-301 | Start Date*: 2012-05-04 | |||||||||||
Sponsor Name:Durata Therapeutics, Inc | |||||||||||||
Full Title: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY STUDY TO COMPARE THE EFFICACY AND SAFETY OF DALBAVANCIN TO A COMPARATOR REGIMEN (VANCOMYCIN AND LINEZOLID) FOR THE TREATMENT OF ACUTE BACTERIAL SKI... | |||||||||||||
Medical condition: acute bacterial skin and skin structure infections (abSSSI) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003931-12 | Sponsor Protocol Number: BXU513667 | Start Date*: 2017-12-13 | |||||||||||
Sponsor Name:Baxter Healthcare Corporation | |||||||||||||
Full Title: A Randomized Controlled Non-inferiority Study to Evaluate the Efficacy and Safety of Hemopatch Compared to TachoSil in Preventing or Reducing Postoperative Air Leaks After Pulmonary Resection. | |||||||||||||
Medical condition: Postoperative air leakage. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002130-40 | Sponsor Protocol Number: DUR001-302 | Start Date*: 2011-11-23 | |||||||||||
Sponsor Name:Durata Therapeutics, Inc | |||||||||||||
Full Title: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY STUDY TO COMPARE THE EFFICACY AND SAFETY OF DALBAVANCIN TO A COMPARATOR REGIMEN (VANCOMYCIN AND LINEZOLID) FOR THE TREATMENT OF ACUTE BACTERIAL SK... | |||||||||||||
Medical condition: acute bacterial skin and skin structure infections (abSSSI) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) LT (Completed) HU (Completed) LV (Completed) EE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-000419-15 | Sponsor Protocol Number: DUR001-303 | Start Date*: 2014-07-28 | |||||||||||
Sponsor Name:Durata Therapeutics International B.V. | |||||||||||||
Full Title: A Phase 3b, Double-Blind, Multicenter, Randomized Study to Compare the Efficacy and Safety of Single Dose Dalbavancin to a Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin ... | |||||||||||||
Medical condition: Acute Bacterial Skin and Skin Structure Infections | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LV (Completed) EE (Completed) HU (Completed) BG (Completed) HR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-003220-36 | Sponsor Protocol Number: 45112 | Start Date*: 2014-05-21 |
Sponsor Name:Albert Schweitzer hospital | ||
Full Title: Remifentanil use for procedural sedation and analgesia in the emergency department | ||
Medical condition: The research will be conducted in patients that need short painfull treatment in the emergency department and with an indication for PSA. These treatments include: repositioning of fractures, repos... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
